ATE192040T1 - Wirkstoff gegen arteriosklerose - Google Patents
Wirkstoff gegen arterioskleroseInfo
- Publication number
- ATE192040T1 ATE192040T1 AT95909975T AT95909975T ATE192040T1 AT E192040 T1 ATE192040 T1 AT E192040T1 AT 95909975 T AT95909975 T AT 95909975T AT 95909975 T AT95909975 T AT 95909975T AT E192040 T1 ATE192040 T1 AT E192040T1
- Authority
- AT
- Austria
- Prior art keywords
- active ingredients
- proliferation
- smooth muscle
- muscle cells
- arteriosclerosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11914694 | 1994-05-31 | ||
PCT/JP1995/000277 WO1995032714A1 (fr) | 1994-05-31 | 1995-02-24 | Depresseur de l'arteriosclerose |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE192040T1 true ATE192040T1 (de) | 2000-05-15 |
Family
ID=14754063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95909975T ATE192040T1 (de) | 1994-05-31 | 1995-02-24 | Wirkstoff gegen arteriosklerose |
Country Status (8)
Country | Link |
---|---|
US (1) | US5840741A (de) |
EP (1) | EP0766963B1 (de) |
KR (1) | KR970703147A (de) |
AT (1) | ATE192040T1 (de) |
AU (1) | AU702727B2 (de) |
CA (1) | CA2190750A1 (de) |
DE (1) | DE69516519T2 (de) |
WO (1) | WO1995032714A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002072580A1 (fr) * | 2001-02-26 | 2002-09-19 | Mitsubishi Pharma Corporation | Preventifs et/ou remedes contres des maladies renales et l'insuffisance renale |
US20070225301A1 (en) * | 2006-02-13 | 2007-09-27 | Astion Inflammation Aps | Treatment of acne and other diseases |
NZ577467A (en) * | 2006-12-18 | 2012-04-27 | Cardoz Ab | Combination of pemirolast and a statin for use in the treatment of inflammatory disorders |
ES2395120T3 (es) * | 2006-12-20 | 2013-02-08 | Cardoz Ab | Combinación de pemirolast y ramotrobán para su uso en el tratamiento de transtornos inflamatorios |
WO2009007680A2 (en) | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combinations comprising a mast cell inhibitor and a statin for use in the treatment of inflammatory disorders |
WO2009007679A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist |
WO2009007675A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist |
WO2009007673A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist |
DE102014222804B4 (de) | 2014-11-07 | 2023-12-28 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung und Verfahren zum Bestimmen einer Wandschubspannung und System zur Erkennung von Arteriosklerose |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES390598A1 (es) * | 1970-05-21 | 1973-06-16 | Pfizer | Un procedimiento para preparar 4-amino - 6,7,8 - trialcoxi-quinazolinas sustituidas en la posicion 2. |
JP3116970B2 (ja) * | 1991-06-12 | 2000-12-11 | 三菱東京製薬株式会社 | ペミロラストカリウムの徐放性製剤 |
-
1995
- 1995-02-24 EP EP95909975A patent/EP0766963B1/de not_active Expired - Lifetime
- 1995-02-24 AU AU18239/95A patent/AU702727B2/en not_active Ceased
- 1995-02-24 CA CA002190750A patent/CA2190750A1/en not_active Abandoned
- 1995-02-24 US US08/737,680 patent/US5840741A/en not_active Expired - Fee Related
- 1995-02-24 KR KR1019960706787A patent/KR970703147A/ko not_active Application Discontinuation
- 1995-02-24 AT AT95909975T patent/ATE192040T1/de not_active IP Right Cessation
- 1995-02-24 DE DE69516519T patent/DE69516519T2/de not_active Expired - Fee Related
- 1995-02-24 WO PCT/JP1995/000277 patent/WO1995032714A1/ja active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE69516519D1 (de) | 2000-05-31 |
US5840741A (en) | 1998-11-24 |
DE69516519T2 (de) | 2000-10-12 |
EP0766963A1 (de) | 1997-04-09 |
EP0766963B1 (de) | 2000-04-26 |
KR970703147A (ko) | 1997-07-03 |
CA2190750A1 (en) | 1995-12-07 |
WO1995032714A1 (fr) | 1995-12-07 |
AU1823995A (en) | 1995-12-21 |
AU702727B2 (en) | 1999-03-04 |
EP0766963A4 (de) | 1997-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE370138T1 (de) | Neue imidazopyridine und ihre verwendung | |
MY107341A (en) | Novel hydroxamic acid and n-hydroxyurea derivatives and their use | |
DE69410121D1 (en) | Dihydro pyrazolopyrrole | |
TR199801642T2 (xx) | Tedavide faydal� olan karbamik asitlerin azabisiklik esterleri. | |
HK1021699A1 (en) | Pentafluorobenzenesulfonamides and analogs. | |
TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
TR199802060T2 (xx) | Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�. | |
NZ513096A (en) | Compositions for treating inflammatory response | |
IS7839A (is) | 4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar | |
ATE161531T1 (de) | Acridine-1,8-dionderivate als therapeutisches mittel | |
TR199902495T2 (xx) | Bile�imler. | |
ATE192040T1 (de) | Wirkstoff gegen arteriosklerose | |
DE69223736D1 (de) | Acridine-1,8-Dionderivate als therapeutisches Mittel | |
DE69519385D1 (de) | Chinazolinon-arzneimittel sowie deren verwendung | |
CA2386685A1 (en) | Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases | |
ATE297926T1 (de) | Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen | |
DE69103773D1 (de) | Derivate von hydroxaminsäure die lipoxygenase hemmen. | |
DE69402004D1 (de) | Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen | |
BR9808546A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratar ou reduzir o risco de doenças ou condições do ser humano, tratar ou reduzir o risco de doença inflamatória e o risco da dor em uma pessoa que sofre, ou em risco, da dita doença e para a preparação do composto | |
ES2168119T3 (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
SE9802650D0 (sv) | Compounds | |
ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |